Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-10-01

Clinical Trial Update: The Safety and Effectiveness of Adefovir Dipivoxil in the Treatment of HIV-Infected Patients [Phase 3]

View source ↗

Summary

This update reports on a Phase 3 trial evaluating the safety and effectiveness of adefovir dipivoxil in HIV-infected patients, including those with cytomegalovi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hepsera (adefovir dipivoxil)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Cytomegalovirus Infections, HIV Infections | Phase 3 | Status: COMPLETED